PARIS–(Business WIRE)–Feb 3, 2021– TISSIUM, a privately-owned medtech corporation creating biomorphic programmable polymers for tissue reconstruction, announced now that it has additional to its management
PARIS–(Business WIRE)–Feb 3, 2021– TISSIUM, a privately-owned medtech corporation creating biomorphic programmable polymers for tissue reconstruction, announced now that it has additional to its management